Latest Articles

In "How to Change Your Mind," Michael Pollan Explores Resurgence of Psychedelic Medicine

By Ellen Kanner, Contributing Writer

After decades on the margins of both polite society and medical research, psychotropic compounds such as psilocybin, LSD, MDMA, and the like, are once again the focus of serious clinical investigation as potential therapies for a host of psychological and neurological conditions. In his newest book, How to Change Your Mind, popular author explores the resurgence of psychedelic medicine without bias, agenda, or pretense.

Is Galectin-3 Inhibition a Key to Reducing Heart Failure?

By Isaac Eliaz, MD, LAc, Contributing Writer

A fast-growing body of data points to galectin-3 (Gal-3) -- an adhesive cell surface protein—as a potential therapeutic target for reducing cardiovascular morbidity and mortality. Modified Citrus Pectin, a natural substance derived from citrus fruit peels, is the only known natural compound that can bind Gal-3, potentially reducing CVD risk.

Vitamin D Research Roundup

By Becky Wright, Contributing Writer

Findings from the massive VITAL study may have dashed the hope that vitamin D supplementation can prevent cardiovascular disease and cancer. But there are many other reasons to consider using this important vitamin. Here's a roundup of recent findings.

How the Endocannabinoid System Modulates Stress

By Carrie Decker, ND, Contributing Writer

In recent years, there has been a lot of interest--among practitioners and patients alike--in the impact of cannabis and cannabis-derived compounds for the modulation of pain, mood, inflammation, and immune system responsiveness. It should not be surprising that the endocannabinoid system (ECS) also plays a regulatory role in the body’s stress response mechanisms.

Terry Wahls: Applying Functional Medicine to Reverse Multiple Sclerosis

By Erik Goldman, Editor

When Dr. Terry Wahls first began speaking about how she had reversed her own case of multiple sclerosis using nutritional and lifestyle interventions, she was quite literally banned by the National Multiple Sclerosis Society. "They told me I was creating false hope," she says. Fortunately, things have changed. Over the last decade, Wahls has helped hundreds of MS patients slow the disease progression and in some cases reverse it completely. And the MS Society now funds her research.

Two Landmark Studies Shed New Light--and Shadow-- on Omega-3s for CVD

By William H. Harris, PhD, Contributing Writer

Two pivotal studies on omega-3s —the long awaited REDUCE-IT and VITAL trials, attempt to clarify the clinical roles of omega-3s for cardiovascular risk reduction. While many of the mainstream headlines took a negative view of the findings, the data actually show some meaningful benefits from omega-3s. Dr. Bill Harris, developer of the Omega-3 Index test, weighs in on the negative and positive messags of these important studies.